| (Values in U.S. Thousands) | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 |
| Sales | 821,460 | 851,570 | 869,230 | 770,510 | 774,240 |
| Sales Growth | -3.54% | -2.03% | +12.81% | -0.48% | -5.07% |
| Net Income | -1,177,520 | 36,250 | 30,130 | 8,370 | 32,620 |
| Net Income Growth | -3,348.33% | +20.31% | +259.98% | -74.34% | -52.12% |
Acadia Healthcr Company (ACHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Acadia Healthcare Company, Inc. provides behavioral health care services in the United States. The U.S. segment comprises acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, outpatient community-based services, wholly-owned facility, and also comprehensive treatment centers (CTCs). For the services rendered in its facilities, the company receives payments from (i) state governments under their respective Medicaid and other programs; (ii) commercial insurers; (iii) the federal government under the Medicare program administered by CMS; (iv) public funded sources in the U.K.; and (v) individual patients and clients.
Fiscal Year End Date: 12/31